Mood disorders Flashcards

1
Q

Unipolar depression epidemiology

A
Avg age of onset 29
ave # of lifetime episodes: 4
Prevalence: 12 month - 7%
lifetime - 17%
all depression life-time prevalence: 21
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Unipolar depression risk factors

A
female sex - 1.5-3x starting in early adolescence
divorce
age
non-black&nonhispanic,
non-white
non-studying adolescent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Major depression diagnosis

A
MDD = major depressive disorder; (MDE: episode)
Neurovegetative/vegetative symptoms
DSIGECAPS:
>=5 of the following for >= 2 weeks, one of criteria must be either depressed mood or anhedonia:
Depressed mood
Sleep disturbance
loss of Interest in pleasurable activities
Guilt
low Energy
Concentration difficulties
Appetite disturbance
Psychomotor retardation
Suicidal ideation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Major depressive disorder comorbidities

A
borderline personality disorder
anxiety disorders
OCD
eating disorders
substance misuse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

BAD-I diagnosis

A
>=1 manic episode +/- MDEs
Expansive/irritable mood nad persistently increased goal-directed activity or energy plus >=3 (or >=4 if mood is only irritable) of the following, lasting >=1 week:
DIGFAST
Distractiliby
Increase in goal-directed activity
Grandiosity
Flight of ideas
Activities with high potential for painful consequences
Sleep decreased
Talkative/pressure of speech

Marked FUNCTIONAL IMPAIRMENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

BAD-II diagnosis

A

Abnormally/persistently elevated, expansive, or irritable mood plus abnormally & persistently increased activity/energy lasting >-4 days, during which >=3 of following occur:
DIGFAST

Unequivocal change in functioning observable by OTHERS
Episode is not severe enough to cause marked impairment in function/require hospitalization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Bipolar affective disorder comorbidities

A

ADHD
substance misuse
anxiety disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bipolar I overview

A

> =1 manic episode +/- depressive episodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bipolar II overview

A

> =1 hypomanic episode +/- >=1 depressive episodes

never had full mania

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cyclothymic disorder diagnosis

A

> =2 y (1 in children/adolescents), numerous periods with hypomanic symptoms that do not meet criteria for hypomanic episode + numerous periods with depressive diagnoses that do not meet criteria for MDE
No symptom-free period >=2 mo at a time
during 2 y period, hypomanic/depressive symptoms have been present for at least half of the time
Have never met criteria for MDE, manic episode or hypomanic episode
Symptoms cause clinically significant distress or impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

GMC rule out

A

general medical condition!
TSH, Na, B12, UTI
Liver disease, renal disease, cardiac disease, dementia, neurological disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dysthymia diagnosis

A

persistent depressive disorder
Depressed mood for most of day, for more days than not, for >=2 years (1 in children/adolescents)
While depressed, >=2 of :
- vegetative symptoms: appetite/sleep/energy changes
- psychological symptoms: low self-esteem, poor concentration/indecisiveness, feeling of hoplelessness

No symptom free period >=2 months at a time
clinically significant distress or impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Biogenic amine hypothesis

A

changes in neurotransmitter levels and regulation
deficiencies in dopamine, serotonin, norepinephrine
leading to receptor upregulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Neurobiology of mood disorders

A

Biogenic amine hypothesis
post-synaptic receptor changes
neuropeptide, neuroendocrine and hormonal changes (cortisol, TSH)
regional brain dysfunction (blood flow, regional metabolism alterations)
Signal transduction abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Norepinephrine role in mood

A

energy
interest
motivation
anxiety, irritability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Serotonin role in mood

A
impulsivity
sex
appetite
aggression
anxiety
irritability
17
Q

Dopamine role in mood

A
motivation
drive
sex
appetite
aggression
18
Q

Signal transduction abnormalities in depression

A

Brain Derived Neuropathic factor (BDNF)
sustains viability of neurons
Repressed under stress, potentially leading to atrophy of hippocampus
5HT/NE can help regulate BDNF
Imaging studies confirm reduced volume of hippocampus in depression and anxiety

19
Q

Pathophysiology of bipolar disorders

A
not well understood!
NT theories
Changes in GABA, ACh
Sensitization/kindling theories
Hormones (cortisol, thyroid)
changes in electrolyte balance
alterations in membrane/secondary messenger systems
Circadian rhythm theories
genetics
20
Q

Risk factors for bipolar disorder

A

Family history - 75% concordance in twins
Seasonal changes
Environmental stressors
Hx of antidepressant use/electroconvulsive therapy

21
Q

Catecholamine theory

A

depression related to decreased catecholaminergic NT caused by NE deficiency
Depletion studies showed relapse in previously controlled depression
Animal models of altered catecholamine metabolism show abnormal exploratory behaviour, conditioned avoidance and reward-seeking behaviour

22
Q

Serotonin production metabolism

A

Tryptophan –> 5-hydroxy tryptophan –> serotonin

23
Q

Serotonin in depression

A

low levels of 5HT metabolite 5HIAA reported in CSF in depressed patients
Relapse in patients previously well-controlled with SSRIs

24
Q

Consequences of interference with serotonin metabolism

A

irritability
insomnia
hyperactivity
hypersexual behaviours

25
Q

Monoamine hypothesis of depression

A

Depression caused by decreased levels of centrally available monoamines (NE, 5HT)
Cause unknown
Evidence: antidepressants increase monoamine levels
Reserpine: depletion of monoamines by irreversibly blocking vesicular monoamine transporter may precipitate depression in some patients
Biochemical effect of antidepressants immediate, but clinical effect takes a while (antidepressants lead to compensatory adaptive changes in receptors - desensitization)
5HT/NE/DA depletion does not induce depression in healthy subjects
Antidepressants are not effective in all patients

26
Q

Newer theories of depression

A

Anti-depressants produce secondary transcriptional and translational changes –> mediate molecular/cellular plasticity –> normalize limbic/cortical circuits

27
Q

Neuroanatomy in depression

A

Dysfunctional connectivity between regions of frontal cortical and limbic system
Decreased size of frontal/cingulate cortices, amygdala
Activity of amygdala increased
Hippocampal volume reduced (associated with greater lifetime depression, stressful life events)
Hippocampus is the major site of neurogenesis in adult brain

28
Q

Prefrontal cortex symptoms in depression

A

guilt, suicidality, worthlessness
mood
psychomotor fatigue (mental)
concentration, interest, pleasure

29
Q

Amygdala symptoms in depression

A

guilt
suicidality
worthlessness
mood

30
Q

HPA axis in mood disorders

A

Dysfunction of HPA axis established in depression –> excess secretion of cortisol
Dexamethasone non-suppression more common in depression (impaired feedback regulation)
Changes in HPA axis only present in ~50% of patients
Chronic secretion of cortisol can alter cognitive function, decrease hippocampal volume
Brain changes likely take place after first episode
Amygdala stimulates hypothalamus to produce CRF, Hippocampal inhibits hypothalamus

31
Q

Cortisol –> hippocampal volume

A

Direct toxic effects / neurotrophic factors

Chronic stress suppresses BDNF

32
Q

Genetics of depression

A

twin concordance 35-50% for major depression (lower than bipolar)
No specific genes
Carriers of short form of serotonin transporter –> higher risk for depression if they also experience stressful life experiences
- associated with increased activation of amygdala in response to fearful faces

33
Q

Depression and immune system

A

Viral/bacterial infection –> sickness behaviour
Overlap significantly with symptoms of depression
Inflammatory disease/taking interferons –> increased risk of psychiatric disorders

34
Q

Pathophysiology of bipolar disorder

A

Less known
Manic: increased catecholamines
Likely due to dysfunction of same circuits as depression (GABA/glutamate, HPA axis)
Abnormalities in cellular signal transduction cascades, second messenger systems, oxidative stress, dysregulation of energy metabolism, myelination
Highly heritable, genetic overlap with schizophrenia

35
Q

SAD PERSONS scale

A
for suicide risk
Sex (male)
Age (15-24, >65)
Depression
Prior history
Ethanol abuse
Rational thinking loss (psychosis)
Support system loss
Organized plan
No SO
Sickness
36
Q

IS PATH WARM

A
dynamic factors of suicide risk to determine need for further assessment
Ideation
Substance abuse
Purposelessness
Anxiety
Trapped
HOpelessness
Withdrawal
Anger
Recklessness
Mood change